Literature DB >> 4187526

Bence Jones proteins and light chains of immunoglobulins. II. Immunochemical differentiation and classification of kappa-chains.

A Solomon, C L McLaughlin.   

Abstract

Three distinct classes of kappa light polypeptide chains have been detected immunochemically by an antiserum (R185) prepared against a kappa Bence Jones protein with a glutamyl amino terminal residue. This antiserum had specificity for kappa light chains with glutamyl amino terminal residues and differentiated kappa-chains with aspartyl amino terminal residues into two classes: the three kappa-chain classes have been designated as kappa(glu), kappa(aspII), and kappa(aspI). The ability of antiserum R185 to detect these antigenic differences on the intact immunoglobulin molecule, as well as on the isolated light chain or Bence Jones protein, made feasible the direct classification of type K myeloma proteins and M-macroglobulins (Waldenström). The multispecificity of the antiserum permitted the quantitation of type kappa(glu) light chains in normal, hypergammaglobulinemic, and hypogammaglobulinemic sera. Whereas the distribution of myeloma proteins and Bence Jones proteins in the kappa(glu) class correlated with the distribution of kappa(glu) chains in normal and hypergammaglobulinemic sera, the M-macroglobulins in the kappa(glu) class represented 90% of the total M-macroglobulins tested and revealed a marked divergence from the range of 24-31% of kappa(glu) immunoglobulins in normal sera. A preponderance of kappa(glu) chains was detected in the sera from patients with non-sex-linked hypogammaglobulinemia and represented 60-77% of the total type K light chain content. The controlled cleavage of a Bence Jones protein representative of each kappa-chain class into its variant half and constant half made possible the localization on the light polypeptide chain, the reactive sites for which antiserum R185 had specificity. The correlations between immunochemical and structural classification of kappa light chains are discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4187526      PMCID: PMC2138696          DOI: 10.1084/jem.130.6.1295

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  STRUCTURAL STUDIES OF THE IMMUNOGLOBULINS. I. THE TRYPTIC PEPTIDES OF BENCE-JONES PROTEINS.

Authors:  F W PUTNAM; C W EASLEY
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

2.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

3.  Structural relationships among normal human gamma-globulin, myeloma globulins, and Bence-Jones proteins.

Authors:  F W PUTMAN
Journal:  Biochim Biophys Acta       Date:  1962-10-08

4.  Zone electrophoresis.

Authors:  H G KUNKEL
Journal:  Methods Biochem Anal       Date:  1954

5.  Subgroups of L type Bence-Jones proteins.

Authors:  A Ruffilli; C Baglioni
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

6.  Light chain types of transiently occurring cold haemagglutinins.

Authors:  M Harboe; K Lind
Journal:  Scand J Haematol       Date:  1966

7.  Inv(1) allotype: effect of immunoglobulin G heavy chain subtype on its expression.

Authors:  A G Steinberg; I Rostenberg
Journal:  Science       Date:  1969-05-30       Impact factor: 47.728

8.  Two antigenic subtypes of human lambda immunoglobulin chains.

Authors:  F W Tischendorf; E F Osserman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

9.  Subtypes of Bence-Jones proteins.

Authors:  R L Nachman; R L Engle; S Stein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

10.  CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS.

Authors:  M Mannik; H G Kunkel
Journal:  J Exp Med       Date:  1962-11-30       Impact factor: 14.307

View more
  10 in total

1.  The V kappa IIIb light chain sub-subgroup. II. Isotype expression in acquired hypogammaglobulinaemia and as a function of age.

Authors:  J A Moynihan; R J Looney; G N Abraham
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

2.  Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.

Authors:  F K Stevenson; E V Elliott; G T Stevenson
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

3.  Monoclonal antibodies reactive with idiotypic and variable-region specific determinants on human immunoglobulins.

Authors:  J L Greenstein; A Solomon; G N Abraham
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

4.  Light chain sequences of human IgM cold agglutinins (variable-region subgroups amino-acid sequence-kappa light chain-N-terminal).

Authors:  J D Capra; J M Kehoe; R C Williams; T Feizi; H G Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

5.  VK IIIb expression is altered in acquired and drug-induced hypogammaglobulinaemia.

Authors:  J L Greenstein; G N Abraham
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

6.  Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.

Authors:  A Solomon; C L McLaughlin; J D Capra
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

7.  Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family.

Authors:  M M Newkirk; H Gram; G F Heinrich; L Ostberg; J D Capra; R L Wasserman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

8.  Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.

Authors:  A Solomon
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

9.  Characterization of human rheumatoid factors with seven antiidiotypes induced by synthetic hypervariable region peptides.

Authors:  P P Chen; F Gõni; R A Houghten; S Fong; R Goldfien; J H Vaughan; B Frangione; D A Carson
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

10.  Serological detection of variable region (Vh) subgroups of Ig heavy chains.

Authors:  O Forre; J B Natvig; H G Kunkel
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.